Dual blockade of CD39 together with TIGIT significantly increased MM cell lysis in one of two cell lines in comparison with a single blockade or in both cell lines in comparison with the control treatment (Fig. 5E, F). The gene discussed is ENTPD1; the disease is Miyoshi myopathy.